Analysis of the pharmaceutical market of the Russian Federation of antibacterial drugs for the treatment of conjunctivitis
DOI: 10.22138/2500-0918-2018-15-4-585-593
O.A. Melnikova, A.G. Paivina
Ural State Medical University, Yekaterinburg, Russian Federation
Abstract: The article contains data on the results of marketing research of the Russian pharmaceutical market of antibacterial drugs for the treatment of conjunctivitis included in the State Register of Medicines. The aim of the study was the analysis of the medicines applied to treatment of infectious diseases of eyes, in particular conjunctivitis. Materials and methods. The researches given for carrying out have been taken from the State Register of Medicines, the main by method of a research are structural, comparative and graphic methods. The results of the content analysis of the Russian pharmaceutical market presented by the group «S Sense organs» showed that this group by the number of trade names is 0.5% of the total number of registered medicines and is represented by 29 active substances under the INN and 91 trade names. The specific gravity of monocomponent and combined medicinal preparations is established. The main trends of the assortment formation in 5 subgroups are determined according to the anatomical-therapeutic-chemical classification. The structure of each group of the studied item, where the main characteristics were chosen: international nonproprietary name the name tion, trade names, number of trade names of medicinal products in the group, countries-producers, manufacturers, method of issuance, conditions for the dispensing of medications. Conclusions. These researches prove need of expansion of the range of the soft dosage forms containing an antimicrobial component and show lack of the medicines containing nano-components.
Keywords: pharmaceutical market, conjunctivitis, market research, medical products
Received 07.05.2018
For citation:
Melnikova O.A., Paivina A.G. Analysis of the pharmaceutical market of the Russian Federation of antibacterial drugs for the treatment of conjunctivitis. Vestn. Ural. Med. Akad. Nauki. = Journal of Ural Medical Academic Science. 2018, Vol. 15, no. 4, pp. 585–593. DOI: 10.22138/2500-0918-2018-15-4-585-593 (In Russ)
REFERENCES
1. Majchuk YU. Conjunctivitis Modern Medicinal Therapy. Kratkoe posobie dlya vrachej. 2014 (In Russ).
2. Shahova V. N., Belyaev V. A., Mihailenko V. V., Safonovskaya E. V., Dorohina A. A. Modeling of the intraocular infection process. Sbornik nauchnyh trudov Stavropol'skogo nauchno-issledovatel'skogo instituta zhivotnovodstva i kormoproizvodstva. 2012. 3(1-1) (In Russ).
3. Juzhakov A. M. The main directions in the elimination of removable blindness in the Russian Federation. Materialy Rossijskogo mezhregional'nogo simpoziuma «Likvidatsija ustranimoj slepoty: vsemirnaja initsiativa VOZ. 2003. 27–31. (In Russ).
4. Kozlov R. S., Ivanchik N. V., Gudkov I. V. Multicenter microbial examination of resistance to antibiotics of bacterial pathogens of infectious eye diseases in Russia 2008. (In Russ).
5. Brook I. Ocular infections due to anaerobic bacteria. International ophthalmology. 2001. 24(5): 269-277.
6. Astachov S.U., Vochmyakov A.V. Ophthalmic fluoroquinolones in the treatment and prevention of eye infections. RMJ. Klinicheskaya oftalmologiya. 2008. 1: 28-30. (In Russ).
7. ZHilyakova E. T., Novikov O. O., Popov N. N. Scientific bulletins of the Belgorod State University. Seriya: Medicina. Farmaciya. 2015. Т.30 №10 (207) (In Russ).
8. Kamenskih T. G., Sumarokova E.S., Kolbenev I.O., Borisov A.V., Haibulina N.M. Application of eye drops 0, 5% levofloxacin («Oftakwix», Santen, Finland) in the treatment of infectious diseases of the conjunctiva and cornea. Oftal'mologicheskie vedomosti. 2008. 1(2): 49-53. (In Russ).
9. Kulikov A. Ju., Serpik V. G. Pharmacoeconomic study of the treatment of bacterial conjunctivitis with antibacterial drugs of fluoroquinolones. Farmako`ekonomika. Sovremennaja farmako`ekonomika i farmako`epidemiologija. 2011. Т. 4. № 4: 69-74. (In Russ).
10. Pozdnyakova V. V., Majchuk YU. F. Eye drops Okomistin® in the treatment of infectious conjunctivitis of various etiologies. Oftal'mologicheskie vedomosti. 2012. 5(2): 67-71 (In Russ).
11. Milazzo G., Papa V., Carstocea B., Chercota G., Rodica P., Gafencu O., Santocono M. Topical netilmicin compared with tobramycin in the treatment of external ocular infection //International journal of clinical pharmacology and therapeutics. 1999. 37 (5): 243-248.
12. Baum Zh. Bacterial conjunctivitis: diagnosis and treatment. Novosti MSRPA. 1999. 2. (In Russ).
13. Maichuk Yu. F. The choice of therapy for bacterial and herpesvirus infection in patients with allergic conjunctivitis. Kataraktalnaya i refrakcionnaya hirurgiya. 2009. 9(3): 33-36 (In Russ).
14. Rietveld R. P. ter Riet G., Bindels P. J., Sloos J. H., van Weert H. C. 2004. Predicting bacterial cause in infectious conjunctivitis: cohort study on informativeness of combinations of signs and symptoms. Bmj. 329(7459): 206-210.
15. Sheikh A., Hurwitz B., Cave J. Antibiotics versus placebo for acute bacterial conjunctivitis. Cochrane Database Syst Rev. 2006. 2(2)
16. Moshetovoj L. K., Nesterova A. P., Egorova E. A. Klinicheskie rekomendatsii. Oftal'mologija = Clinical recommendations. Ophthalmology. 2007: 14-17. (In Russ).
17. Bezshejko V.G. Efficacy of antibiotics for bacterial conjunctivitis. Ukraїns'kij medichnij chasopis. 2012. (In Russ).
18. Samujlo E. K. Kozlov R.S., Ivanchik N.V., Krechikova O.I. Resistance to antibiotics of bacterial pathogens of infectious eye diseases in Russia. Porazheniya organa zreniya: materialy yubil. nauch.-prak. konf., posvyashch. 190-letnemu yubileyu osnovaniya kafedry oftal'mologii Voen.-med. akad. im. SM Kirova. 2008: 157 (In Russ).
Authors
Olga A. Melnikova
Dr.Sci. (Pharm.), Professor of Department of management and economy of pharmacy, Associate professor at the Department of pharmacy
newfarmacia@mail.ru
Anna G. Paivina
Postgraduate of the Department of pharmacy
anechka144@e1.ru
Ural State Medical University
Russian Federation, 620028, Yekaterinburg, Repin St., 3
